M&A Deal Summary

Boston Scientific Acquires Intera Oncology

On November 25, 2024, Boston Scientific acquired medical products company Intera Oncology

Acquisition Highlights
  • This is Boston Scientific’s 50th transaction in the Medical Products sector.
  • This is Boston Scientific’s 51st transaction in the United States.
  • This is Boston Scientific’s 6th transaction in Massachusetts.

M&A Deal Summary
Date 2024-11-25
Target Intera Oncology
Sector Medical Products
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition

Target

Intera Oncology

Newton, Massachusetts, United States
Intera Oncology is a medical device company that provides the Intera 3000 Hepatic Artery Infusion Pump and floxuridine – a chemotherapy drug – both of which are approved by the U.S. Food and Drug Administration. Intera Oncology was formed in 2019 and is headquartered in Newton, Massachusetts.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States
Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 14.2B USD (2023)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 66 of 66
Sector (Medical Products) 50 of 50
Type (Add-on Acquisition) 51 of 51
State (Massachusetts) 6 of 6
Country (United States) 51 of 51
Year (2024) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-04 Cortex

Menlo Park, California, United States

Cortex is a medical technology company focused on the development of a diagnostic mapping solution which may identify triggers and drivers outside of the pulmonary veins that are foundational to atrial fibrillation (AF), a heart rhythm disorder affecting nearly 38 million people globally. Cortex is based in Menlo Park, California.

Buy -
Mergr

Product

Company

Legal